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Aim: The aim of this study was to investigate the
current state of duration of seclusion/restraint in
acute psychiatric settings in Japan and the effect of
patient characteristics on duration of seclusion/
restraint.
Methods: During an 8-month period starting from
November 2008, duration of seclusion/restraint
and patient characteristics were investigated in 694
psychiatric inpatients who experienced seclusion/
restraint in three emergency and three acute wards at
four psychiatric hospitals. Reasons for starting
seclusion/restraint were also assessed. Analysis was
performed using generalized linear models, with the
duration of seclusion/restraint as the dependent vari-
able and patient characteristics and reasons for start-
ing seclusion/restraint as independent variables.
Results: Of the patients secluded/restrained, 58.6%
had a primary diagnosis of schizophrenia (F20–F29)
and a large proportion (37.9%) were secluded/
restrained due to hurting others. Median hours of
seclusion/restraint were 204 and 82 h, respectively.
The duration of seclusion was longer for patients with
F20–F29 than those with disorders due to psychoac-
tive substance use (F10–F19) or other diagnoses
(F40–F99), and when the reason was danger of
hurting others. In contrast, the duration of restraint
in female patients and in patients with F10–F19
diagnosis was shorter.
Conclusion: The duration of seclusion/restraint at
acute psychiatric care wards in Japan are much longer
than those reported by previous overseas studies.
Although Japanese structure issues such as more
patients per ward and a lower ratio of nurses need to
be considered, skills for dealing with patients with
primary diagnosis of F20–F29 secluded due to danger
posed to others should be improved.
Key words: acute psychiatry, generalized linear
models, psychiatric inpatient, restraint, seclusion.
IN PSYCHIATRIC INPATIENT settings, seclusionand restraint (S/R) is used as a last resort to ensure
the safety of the patient, other patients, and staff from
disturbed behavior caused by patient symptoms.1
S/R, however, infringes on patient autonomy and
respect.1 Also, patients have a negative attitude
toward S/R: unlike the staff, they do not consider S/R
to be a treatment and feel as if brute force was exer-
cised, and experience feelings of guilt.2–5 The feeling
of being forced into S/R negatively affects efforts to
build relationships with staff members, which in turn
may reduce treatment adherence.6,7
Some relatively large-scale investigations of S/R use
from around the world have been reported, and
include a comparison of use among inpatients with
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schizophrenia in Germany and Switzerland,8 a review
of annual regional data in Finland,9 a review of forced
treatments in 10 European countries,10 and a con-
tinuous annual clinical indicators report of the Aus-
tralian Council on Healthcare Standards.11 These
investigations look at regional and inter-annual
differences, but do not investigate the reasons for
these differences. The reality that is highlighted in
such comparison, however, shows the importance of
understanding the issue in each country and region.8
Several studies have also analyzed how factors such
as sex, age, race, immigration status, or other details
of patient background affect the use of coercive treat-
ment, including S/R as well as involuntary medica-
tion. Studies have shown higher usage rates in men
than women,12,13 in younger patients than older
patients,12–15 in black patients than white patients,12
and in refugees and immigrants than native Danish
subjects.16 Given these results, the issue of how to
deal with patients at high risk for the use of S/R is
being discussed.
With the goal of minimizing or eliminating S/R,
various training programs and projects are being
developed around the world.17–19 In the USA, the six
core strategies were published to minimize S/R.17
Facilities that have participated in the training of
these strategies have reported a reduction in the use
of S/R.20 One of the six core strategies is ‘use of data’.
In order to implement such projects, it is important
to understand the amount of S/R currently used and
to set target values and analyze it.
Hereafter, the term ‘seclusion’ is defined as isola-
tion of an individual in a locked room, and, ‘restraint’
shall be used to refer to mechanical restraint, which is
defined as the use of restraining straps, belts, or other
equipment to restrict movement, while the term
‘physical restraint’ is defined as physically holding an
individual, preventing movement.21
In Japan, according to a national survey of psychi-
atric health and welfare, S/R was used on a single
surveyed date with 7741 inpatients (2.4% of all inpa-
tients) and 5109 inpatients (1.6%) in 2003, respec-
tively, and this grew steadily to reach 8456 (2.7%)
and 8057 (2.6%) by 2008.22 In order to better under-
stand why the use of S/R has not fallen in Japan,
Sugiyama et al. analyzed the frequency of use in
emergency psychiatric wards.23 During a 1-month
observation period, they found that the average hours
of use were 249.6 for seclusion and 172.8 for
restraint. In comparison, the medians in Finland in
2004 for S/R were 17.1 h and 7.0 h, respectively,9 and
only 47.2% of patients in Australia were secluded for
>4 h in a single seclusion episode,11 indicating longer
durations in Japan compared to other countries.24
It was not possible, however, to compare previous
studies closely from the results reported by
Sugiyama et al. First, under the Japanese Mental
Health Act, use of S/R should be recorded in daily
units, so it was not possible to subtract temporary
release hours to determine the actual duration.
Second, the observation period was only 1 month,
which included patients still under S/R for whom
observation had to be terminated, so it was not pos-
sible to determine the actual duration of usage per
patient. Another limitation of the Sugiyama et al.
study was that its analysis did not include consider-
ation of patient characteristics.
The aims of the present study were to (i) obtain
more accurate data on duration of S/R use per patient
in order to clarify the state of S/R in Japan as com-
pared to other countries; and (ii) clarify patient char-
acteristics associated with longer duration of S/R use
so as to identify effective interventions.
METHODS
This study was conducted as a comprehensive
research project jointly by Japan and Finland, as the
Sakura Project with the goal of obtaining knowledge
about the use of S/R in psychiatric hospitals.
Subjects
From among 1232 inpatients admitted to three emer-
gency wards and three acute wards at four psychiatric
hospitals participating in the Sakura Project from 1
November 2008 to 30 June 2009, the present subjects
were 694 patients (56.3%) for whom S/R was used
during the same period. Seclusion was used with 687
patients, while restraint was used with 148 patients.
Of the subjects, 52% were male, and mean age was
45.8 ± 16.7 years.
The average number of beds in the six wards was
46.8, and the average registered nurse allocation was
10 patients per nurse per day in the emergency ward
and 13 patients per nurse per day in the acute ward.
Procedure
As basic patient characteristics, data on sex, age, and
psychiatric primary diagnosis based on International
Classification of Disease 10th version (ICD-10) were
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obtained from medical records. The main reasons for
starting S/R were categorized by the nurse responsible
for the patient, based on the seven categories used for
reporting in Finland: hurting self; hurting others;
jeopardizing own safety; obstructing treatment of
others; damaging property; polydipsia; and other
serious reason.
The daily duration of S/R was recorded according
to the approximate estimation, with 0–8 S/R hours
per day counted as 4 S/R hours, 8–16 h counted as
12 h, 16–24 h counted as 20 h, and the entire day
counted as 24 h. Then, the total S/R hours per patient
were calculated as the sum of daily estimated hours.
The observation period was up to the end of July
2009.
The study protocol was approved by the Ethics
Committee of the National Center of Neurology and
Psychiatry in Japan.
Statistical analysis
Statistical analysis was performed using generalized
linear models on the basis of negative binominal
distribution with S/R hours set as the dependent vari-
able, and patient characteristics and reason for start-
ing S/R as the independent variables. In addition,
dummy variables were used to process categorical
data. Two-tailed P < 0.05 was considered to indicate
statistical significance. All statistical analysis was
performed using SPSS ver15.0 for Windows (SPSS,
Chicago, IL, USA).
RESULTS
Table 1 shows that the most common psychiatric
primary diagnosis of the subjects was schizophrenia
(F20–F29) at 58.6%, and the most common reason
for starting S/R was ‘hurting others’, at 37.9%.
Figure 1(a) shows that, for seclusion, the
mean ± SD was 314.8 ± 332.4 h and the median
(interquartile range; IQR) was 204 h (IQR,
96–416 h), with the highest prevalence occurring
from 120 to 144 h.
Figure 1(b) shows that, for restraint, the mean was
142.0 ± 230.4 h and the median (IQR) was 82 h (29–
159 h), with the highest prevalence occurring
between 24 and 48 h.
Significant models were obtained from generalized
linear models with S/R duration set as the dependent
variable. Table 2 shows that the duration of seclusion
was significantly longer for patients with F20–F29
diagnosis than for those with disorders due to psy-
choactive substance use (F10–F19) or other diagno-
ses (F40–F99), and for patients starting seclusion due
to the risk of ‘hurting others’ than for other reasons
for starting seclusion.
Table 3 shows that the duration of restraint was
significantly longer for men than for women, and
longer for patients with F20–F29 diagnosis than for
those with F10–F19 diagnosis. No significant differ-
ence was observed in regard to reasons for starting
restraint.
DISCUSSION
This study has found that the duration of seclusion
(median, 204 h) and restraint (median, 82 h) on
Japanese hospital wards responsible for acute psychi-
atric care are essentially 10-fold higher than those
reported by previous overseas studies.9,11,24 It is
crucial to clarify the reasons behind these long S/R
durations.
Structure issues, such as patient-to-staff ratios and
the number of patients in wards, are factors thought
to influence the duration of S/R.25 In Japan, the
Table 1. Patient characteristics and reasons for starting
seclusion/restraint










F40–F99 (others) 79 11.4
Reason for starting seclusion/
restraint
Hurting self 126 18.2
Hurting others 262 37.9




Damaging property 11 1.6
Polydipsia 4 0.6
Other serious reason 62 9.0
SD, Standard deviation.
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average number of beds on each emergency ward is
43.9,23 and the standard nurse-to-patient ratio is
0.50. In the UK, the average number of beds per ward
is 21, with a nurse-to-bed ratio of 0.99,26 while in
Norway, the average number of beds per ward is 11
with a staff-to-bed ratio of 3.5.27 In the UK, restraint is
not used and physical restraint is used for 10–20 min.
In Norway, seclusion is used for 3.0 h and restraint
for 7.9 h.24
These differences in figures suggest that fewer
patients per ward and a higher ratio of nurses or other
staff would make it possible to promote a better
understanding of each patient, making it possible to
develop individualized response strategies to resolve
difficult situations before applying S/R. Moreover,
because staff can easily increase the frequency of
patient observations, they frequently make efforts to
substitute constant observation for S/R.28 Care struc-
tures with a small-scale ward with a high number of
staff seem to be related to shorter S/R duration.25
The acquisition of more accurate data on S/R dura-
tion, and comparison with previous studies from
other countries have shed more light on the current
state of S/R practices in Japan and the issues to be
addressed. Although Japan has the same basic philo-
sophical goal as other countries, in the using of S/R
only as a last resort when no other alternatives are
effective, the durations of S/R use have been shown to
be longer in Japan.23 For this reason, the care struc-
tures and processes in S/R use in other countries must
be considered so as to reduce the current S/R dura-
tions in Japan.
This study showed that S/R duration is affected by
patient clinical background. The fact that S/R dura-
tion was shorter for patients with F10–F19 diagnosis
than for those with F20–F29 diagnosis suggests that
S/R for patients with F10–F19 diagnosis is used for
temporary acute condition such as delirium or excite-
ment, and such patients regain their reality-testing
abilities often in a short time.
Another suggested factor in seclusion duration was
the reason for starting it; when comparing ‘hurting
others’ to other reasons, there appears to be a ten-
dency to delay release out of concern for the safety of
the patient and others.
It is important to intervene with a focus on patients
with F20–F29 diagnosis (58.6%) and patients for
whom S/R was started due to the danger of hurting
others (37.9%), because these two groups comprise
the majority of patients who received seclusion. One
strategy for dealing with seclusion started for the
reason of ‘hurting others’ could be to promote the use
of the Comprehensive Violence Prevention and Pro-
tection Program (CVPPP) in Japan. CVPPP is a com-
prehensive program to deal with violence effectively



















Figure 1 Hours spent in (a) seclusion (n = 687) and (b)
restraint (n = 148).
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developed in the UK for use in Japan. The program
includes breaking away29 and control and restraint
training,30,31 as well as the prediction and prevention
skills mentioned in the clinical guideline of the
National Institute for Health and Clinical Excellence
(NICE).32 The program is steadily growing in Japan:
as of 2010, 2764 individuals (4.3% of the 63 556
full-time nurses working in psychiatric hospitals as of
2007) have attended a 4-day program for training the
trainers to be able to disseminate the techniques
within their own facilities. The hypothesis of reduc-
ing the duration of seclusion, started for the reason of
‘hurting others’, should be validated as more staff
members learn the CVPPP techniques.
A sex difference was observed with regard to
restraint, with men having significantly longer
Table 2. Factors in duration of seclusion (n = 682)
Estimate SE Wald 95%CI Wald χ2 P
Sex
Male Reference
Female −0.031 0.0786 −0.185 to 0.123 0.155 0.694
Age (years) 0.001 0.0025 −0.004 to 0.005 0.049 0.825
Diagnosis
F0 0.080 0.1639 −0.241 to 0.401 0.238 0.626
F1 −0.580 0.1456 −0.865 to −0.294 15.847 0.000***
F2 Reference
F3 0.004 0.1177 −0.227 to 0.234 0.001 0.975
F40–F99 (others) −0.574 0.1262 −0.822 to −0.327 20.731 0.000***
Reason for starting seclusion/restraint
Hurting self −0.308 0.1129 −0.529 to −0.087 7.451 0.006**
Hurting others Reference
Jeopardizing own safety −0.331 0.1100 −0.547 to −0.115 9.051 0.003**
Other −0.261 0.1013 −0.460 to −0.063 6.668 0.010*
*P < 0.05; **P < 0.01; ***P < 0.001. CI, confidence interval; estimate, partial regression coefficient; SE, standard error.
Table 3. Factors in duration of restraint(n = 146)
Estimate SE Wald 95%CI Wald χ2 P
Sex
Male Reference
Female −0.431 0.1843 −0.792 to −0.070 5.468 0.019*
Age 0.010 0.0055 −0.001 to 0.020 3.074 0.080
Diagnosis
F0 0.221 0.3626 −0.490 to 0.932 0.372 0.542
F1 −0.907 0.3490 −1.591 to −0.223 6.749 0.009**
F2 Reference
F3 0.301 0.2878 −0.263 to 0.865 1.095 0.295
F40–F99 (others) −0.386 0.2995 −0.973 to 0.201 1.660 0.198
Reason for starting seclusion/restraint
Hurting self 0.170 0.2746 −0.368 to 0.709 0.385 0.535
Hurting others Reference
Jeopardizing own safety 0.118 0.2211 −0.315 to −0.551 0.284 0.594
Other −0.379 0.2577 −0.884 to 0.126 2.162 0.141
*P < 0.05; **P < 0.01. CI, confidence interval; estimate, partial regression coefficient; SE, standard error.
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duration compared to women, with no effect of
reason for restraint. Given that restraint limits the
patient even more than seclusion does, it is chosen in
the more severe cases. This suggests that delayed
attempts in temporary release are because the patient
is male and not due to the reason for restraint.
Regarding the use of S/R and patient characteris-
tics, some studies have separated patients into two
groups, receiving or not receiving S/R, with reports of
more use of S/R for male patients, younger patients,
black patients, and immigrant patients.12–16 Almost
none, however, has investigated the effect of these on
the duration of S/R. For countries using S/R from
several hours to <1 day, only the use of S/R and not
its duration may be important in determining the
effect of patient characteristics. There are also coun-
tries promoting projects to reduce seclusion, such as
the Netherlands, which reports a seclusion duration
of 16 days,33,34 and there are probably other countries
such as Japan that have an S/R duration lasting
several days. Accumulating knowledge about patient
characteristics affecting S/R duration will be impor-
tant for these countries.
Conclusion
The median S/R duration in acute psychiatric wards
in Japan was longer than those reported in previous
studies. It is necessary to identify differences in care
structure and process as compared to countries with
lower S/R duration. This study also found that the
duration of S/R is affected by patient clinical back-
ground. In working to minimize the duration of
seclusion, the benefits of skills for care of patients
with danger of hurting others, such as CVPPP pro-
moted in Japan, should be validated.
The number of hospitals participating in this study
as well as the range of ward types was limited. In
psychiatric care in Japan, S/R is primarily used with
patients who are difficult to manage in chronic wards,
and patients with cognitive disorders in wards spe-
cialized in dementia care. Because other factors could
be influencing the duration of S/R in patients in such
wards, additional research is needed that analyzes a
wider range of targeted wards.
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